Jakarta - PT Kalbe Farma Tbk (KLBF) this year targets double-digit growth with the innovation technology strategy that has been and is being carried out.

Director of Kalbe Farma Bernadus Winata said the company produces complete products according to the needs and demands of the community, ranging from curative, preventive, diagnostic to nutrition medicines and a digital distribution platform.

"This strategy can maintain Kalbe's growth for the better and this year it will return to double digit growth," he said at the Public Expose (PubEx) Live 2021 event in Jakarta on Wednesday (8/9).

This year, the company targets sales performance and net profit to grow up to 10%, assuming that the rupiah exchange rate is Rp15,000 per US dollar, and Indonesia's GDP growth projection is 4 to 5%.

Meanwhile, the growth of each of the company's business lines was quite significant, which was contributed by the distribution and logistics bu